MedTrace Logo

Understanding Genetic Incidental Findings in Your Family (UNIFY Study)

NCT02560896 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2023-06-06

No results posted yet for this study

Summary

Currently, there is no clear legal or ethical guidance about how researchers and IRBs ought to proceed when the research participant in a biobank is deceased and there is clinically relevant information that could be disclosed to family members. This study is designed to test a procedure offering genetic information to family members of research participants who participated in a pancreatic cancer biobank in a Health Insurance Portability and Accountability Act (HIPAA) -compliant design.

Conditions

  • Familial Pancreatic Cancer

Sponsors & Collaborators

Principal Investigators

  • Gloria Petersen, PhD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2019-11-04
Completion
2019-11-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02560896 on ClinicalTrials.gov